Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- PODD
- Price
- 246.34
- Stock movement up
- +3.60 (1.48%)
- Company name
- Insulet Corporation
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Devices
- Market cap
- 17.34B
- Ent value
- 18.30B
- Price/Sales
- 6.40
- Price/Book
- 11.44
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- 70.18
- Forward P/E
- 30.46
- PEG
- -
- EPS growth
- 101.65%
- 1 year return (CAGR)
- -12.68%
- 3 year return (CAGR)
- -4.91%
- 5 year return (CAGR)
- -2.67%
- 10 year return (CAGR)
- 25.11%
Last updated: 2026-03-12
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
PODD does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 70.18 |
| Price to OCF | 30.46 |
| Price to FCF | 45.91 |
| Price to EBITDA | 35.64 |
| EV to EBITDA | 37.61 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 6.40 |
| Price to Book | 11.44 |
| EV to Sales | 6.76 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 70.40M |
| EPS (TTM) | 3.50 |
| FCF per share (TTM) | 5.34 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 2.71B |
| Gross profit (TTM) | 1.94B |
| Operating income (TTM) | 473.90M |
| Net income (TTM) | 247.10M |
| EPS (TTM) | 3.50 |
| EPS (1y forward) | 8.09 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 71.63% |
| Operating margin (TTM) | 17.50% |
| Profit margin (TTM) | 9.12% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 716.10M |
| Net receivables | 516.90M |
| Total current assets | 1.89B |
| Goodwill | 51.60M |
| Intangible assets | 117.10M |
| Property, plant and equipment | 1.25B |
| Total assets | 3.19B |
| Accounts payable | 75.00M |
| Short/Current long term debt | 1.05B |
| Total current liabilities | 680.10M |
| Total liabilities | 1.68B |
| Shareholder's equity | 1.52B |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 569.30M |
| Capital expenditures (TTM) | 191.60M |
| Free cash flow (TTM) | 377.70M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | 16.31% |
| Return on Assets | 7.75% |
| Return on Invested Capital | 10.01% |
| Cash Return on Invested Capital | 15.30% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 243.57 |
| Daily high | 249.65 |
| Daily low | 242.18 |
| Daily Volume | 1.23M |
| All-time high | 352.82 |
| 1y analyst estimate | 354.40 |
| Beta | 1.44 |
| EPS (TTM) | 3.50 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 18 Feb 2026 |
Downside potential
Loading...
Downside potential data
| PODD | S&P500 | |
| Current price drop from All-time high | -30.18% | -1.82% |
| Highest price drop | -90.28% | -56.47% |
| Date of highest drop | 11 Mar 2009 | 9 Mar 2009 |
| Avg drop from high | -24.55% | -10.84% |
| Avg time to new high | 20 days | 12 days |
| Max time to new high | 1366 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
17.34B
Marketcap category
Large-cap
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Employees
5400
Website
Investor relations
-
SEC filings
CEO
Shacey Petrovic
Country
USA
City
Acton
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page